The real world evidence solutions market was valued at USD 5.4 billion in 2025, is estimated at USD 6.2 billion in 2026 and is projected to reach USD 24.6 billion by 2036. In 2026, datasets hold 62.5% of component sales and drug development & approvals lead the application segment.